Cointime

Magnitude Biosciences

company

About

Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.

Highlights

Total Funding Amount
$125K £375K
Funding Rounds
4
Investors
1
Employee Profiles
4

Details

Last Funding Type
Seed
Industries
Biotechnology,Fitness,Health Care,Pharmaceutical
Founded date
Nov 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$125K £375K
Magnitude Biosciences has raised a total of $125K £375K in funding over 2 rounds. Their latest funding was raised on Nov 14, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2022 Seed — — — — Detail
Aug 4, 2020 Seed $125K 1 — — Detail
Dec 2, 2019 Seed £225K 1 Northstar Ventures — Detail
Jan 17, 2019 Seed £150K 1 Northstar Ventures — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Magnitude Biosciences is funded by 1 investors. Northstar Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Northstar Ventures — Seed

Employee Profiles

Number of Employee Profiles
4
Magnitude Biosciences has 4 current employee profiles, including Employee Dr Sally Waterman
John O'Brien
Executive
Chris Saunter
Executive
David Weinkove
Executive
Cointime
เนื้อหา
บริษัท